About
Ibio, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 8 2026
iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia
Mar 16 2026
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Mar 9 2026
iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss
Feb 24 2026
iBio to Participate in Upcoming Investor Conferences
Feb 10 2026
iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update
Recent Videos

iBio's 8-K: My Take on the Drug Trial & Warrant Expiration
Apr 08, 2026

iBio, Inc. (0001420720) (Filer) #Shorts
Apr 08, 2026

MAIA Biotechnology, Inc. (0001878313) (Filer) #Shorts
Apr 08, 2026

$$tovx dayif glory are over. I expect severe drop and reverse split.
Mar 24, 2026
Translate